✦ LIBER ✦

Identification of neuronal target areas for nerve agents and specification of receptors for pharmacological treatment

✍ Scribed by Trond Myhrer

Book ID: 116780195
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 325 KB
Volume: 31
Category: Article
ISSN: 0161-813X
DOI: 10.1016/j.neuro.2010.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of pharmacological agents fo

Development of pharmacological agents for targeting neurotrophins and their receptors

✍ H.Uri Saragovi; Kalle Gehring 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Neuronal nicotinic acetylcholine recepto

Neuronal nicotinic acetylcholine receptors as a target for the treatment of neuropathic pain

✍ Michael D. Meyer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 1 views

## Abstract Neuronal nicotinic acetylcholine receptor (nAChR) agonists have been demonstrated to exhibit antinociceptive, antihyperalgesic, and antiallodynic effects across a range of preclinical models of pain. Yet, to date, no drugs have been successfully developed and approved for the treatment

Targets and Emerging Therapies for Schiz

Targets and Emerging Therapies for Schizophrenia (Albert/Pharmacological Schizophrenia) || Metabotropic Glutamate 2/3 Receptor Agonists and Positive Allosteric Modulators of Metabotropic Glutamate Receptor 2 as Novel Agents for the Treatment of Schizophrenia

✍ Albert, Jeffrey S.; Wood, Michael W. 📂 Article 📅 2012 🏛 John Wiley & Sons, Inc. ⚖ 235 KB

Effect of dopamine receptor agonists on

Effect of dopamine receptor agonists on sensory nerve activity: possible therapeutic targets for the treatment of asthma and COPD

✍ Mark A Birrell; Natascia Crispino; David J Hele; Hema J Patel; Magdi H Yacoub; P 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB

Emerging Drugs and Targets for Alzheimer

Emerging Drugs and Targets for Alzheimer's Disease Volume 2 || Chapter 23. Serotonin 5-HT4 Receptors as Pharmacological Targets for the Treatment of Alzheimer's Disease

✍ Martinez, Ana 📂 Article 📅 2010 🏛 Royal Society of Chemistry ⚖ 890 KB

New pharmacological avenues for the trea

New pharmacological avenues for the treatment of l -DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

✍ Blandini, Fabio; Armentero, Marie-Therese 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 469 KB